Genomics in Prostate Cancer and Beyond: Interview with Dr. Colin Collins, Senior Scientist at the Vancouver Prostate Centre
As genomics and computer science converge and advance, precision oncology is advancing from a promising concept to an emerging reality. The Vancouver Prostate Centre (VPC) is a University of British Columbia (UBC) and Canadian Centre of Excellence at the forefront of research into advanced treatment resistant prostate cancer and other cancers utilizing modern genomics and computer science along with other world-leading technologies to improve patient outcomes.
It's free! Log in now to read
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115